PRTK

Paratek Pharmaceuticals, Inc.
PRTK

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

PRTK was delisted on the 20th of September, 2023.

Back to rankings

42 hedge funds and large institutions have $21.8M invested in Paratek Pharmaceuticals, Inc. in 2013 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

33% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 15

92% less call options, than puts

Call options by funds: $46K | Put options by funds: $554K

Holders
42
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$46K
Puts
$554K
Net Calls
Net Calls Change

Top Buyers

1
+$321K
2
+$213K
3
+$165K
4
AQR Capital Management
AQR Capital Management
Connecticut
+$104K
5
Morgan Stanley
Morgan Stanley
New York
+$90.1K

Top Sellers

1
-$316K
2
-$182K
3
-$165K
4
RAM
Roumell Asset Management
Maryland
-$158K
5
Millennium Management
Millennium Management
New York
-$109K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$59K
27
$47K
28
$47K
29
$42K
30
$42K
31
$41K
32
$39K
33
$32K
34
$32K
35
$11K
36
$10K
37
$8K
38
$4K
39
$3K
40
$3K
41
$2
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3